trending Market Intelligence /marketintelligence/en/news-insights/trending/knxn4latsn4vug4wklbjpg2 content esgSubNav
In This List

UK's Realm Therapeutics to list American depositary shares on Nasdaq

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


UK's Realm Therapeutics to list American depositary shares on Nasdaq

Realm Therapeutics PLC, a U.K. developer of topical medicines for skin conditions, is listing its American depositary shares on the Nasdaq Stock Market.

The ADSs will begin trading this month under the ticker RLM.

The London-based company will list 126,857,901 ordinary shares, represented by about 5,074,316 ADSs. Each ADS represents 25 ordinary shares, with a nominal value of 10 pence per share.

Realm said it will not receive proceeds from the transaction.